LTRN vs. TALK

Last updated Jun 4, 2026

LTRN (Lantern Pharma Inc.) and TALK (Talkspace, Inc.) are both stocks. Both are in the Healthcare sector — LTRN in Biotechnology, TALK in Medical Care Facilities. Over the past 5 years, LTRN returned -25.86%/yr vs -12.19%/yr for TALK. At a 0.16 correlation, their price movements are largely independent.

Performance

LTRN vs. TALK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lantern Pharma Inc. (LTRN) and Talkspace, Inc. (TALK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LTRN achieves a 12.21% return, which is significantly lower than TALK's 43.53% return.

LTRN

• 1D: -9.09%
• 1M: 52.47%
• YTD: 12.21%
• 6M: -3.95%
• 1Y: 5.59%
• 3Y*: -12.24%
• 5Y*: -25.86%
• 10Y*: —

TALK

• 1D: -0.19%
• 1M: 0.19%
• YTD: 43.53%
• 6M: 62.81%
• 1Y: 52.79%
• 3Y*: 71.66%
• 5Y*: -12.19%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LTRN vs. TALK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
LTRN Lantern Pharma Inc.	12.21%	-5.02%	-25.47%	-29.14%	-24.31%	-58.55%	57.53%
TALK Talkspace, Inc.	43.53%	17.48%	21.65%	316.19%	-69.02%	-81.78%	7.03%

Correlation

The correlation between LTRN and TALK is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (5Y) Calculated over the trailing 5-year period	0.18
Correlation (All Time) Calculated using the full available price history since Jul 31, 2020	0.16

Fundamentals

Market Cap LTRN : $38.26M TALK : $905.26M
EPS LTRN : -$1.45 TALK : $0.01
PB Ratio LTRN : 11.10 TALK : 8.01
Total Revenue (TTM) LTRN : $0.00 TALK : $238.37M
Gross Profit (TTM) LTRN : $0.00 TALK : $100.68M
EBITDA (TTM) LTRN : -$16.42M TALK : $6.16M

Return for Risk

LTRN vs. TALK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LTRN

LTRN Risk / Return Rank: 46
LTRN Sharpe Ratio Rank: 43
LTRN Sortino Ratio Rank: 50
LTRN Omega Ratio Rank: 51
LTRN Calmar Ratio Rank: 43
LTRN Martin Ratio Rank: 42

TALK

TALK Risk / Return Rank: 72
TALK Sharpe Ratio Rank: 74
TALK Sortino Ratio Rank: 73
TALK Omega Ratio Rank: 72
TALK Calmar Ratio Rank: 71
TALK Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LTRN vs. TALK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and Talkspace, Inc. (TALK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LTRN	TALK	Difference
Sharpe ratio: Return per unit of total volatility	0.06	1.11	-1.05
Sortino ratio: Return per unit of downside risk	0.83	1.90	-1.07
Omega ratio: Gain probability vs. loss probability	1.12	1.24	-0.13
Calmar ratio: Return relative to maximum drawdown	0.07	1.69	-1.62
Martin ratio: Return relative to average drawdown	0.15	4.11	-3.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LTRN vs. TALK - Sharpe Ratio Comparison

The current LTRN Sharpe Ratio is 0.06, which is lower than the TALK Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of LTRN and TALK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LTRN	TALK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.06	1.11	-1.05
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.30	-0.18	-0.13
Sharpe Ratio (All Time) Calculated using the full available price history	-0.26	-0.17	-0.09

Drawdowns

LTRN vs. TALK - Drawdown Comparison

The maximum LTRN drawdown since its inception was -94.89%, roughly equal to the maximum TALK drawdown of -95.17%. Use the drawdown chart below to compare losses from any high point for LTRN and TALK.

Drawdown Indicators

	LTRN	TALK	Difference
Max Drawdown Largest peak-to-trough decline	-94.89%	-95.17%	+0.28%
Max Drawdown (1Y) Largest decline over 1 year	-78.95%	-31.32%	-47.63%
Max Drawdown (3Y) Largest decline over 3 years	-89.48%	-56.35%	-33.13%
Max Drawdown (5Y) Largest decline over 5 years	-93.02%	-94.16%	+1.14%
Current Drawdown Current decline from peak	-84.49%	-56.94%	-27.55%
Average Drawdown Average peak-to-trough decline	-66.20%	-68.57%	+2.37%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.12%	14.34%	+22.78%

Volatility

LTRN vs. TALK - Volatility Comparison

Lantern Pharma Inc. (LTRN) has a higher volatility of 33.75% compared to Talkspace, Inc. (TALK) at 0.90%. This indicates that LTRN's price experiences larger fluctuations and is considered to be riskier than TALK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LTRN	TALK	Difference
Volatility (1M) Calculated over the trailing 1-month period	33.75%	0.90%	+32.85%
Volatility (6M) Calculated over the trailing 6-month period	89.61%	31.23%	+58.38%
Volatility (1Y) Calculated over the trailing 1-year period	96.91%	47.71%	+49.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	85.34%	69.27%	+16.07%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.19%	64.94%	+20.25%

Dividends

LTRN vs. TALK - Dividend Comparison

Neither LTRN nor TALK has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both LTRN and TALK in my portfolio?

LTRN and TALK have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LTRN or TALK?

LTRN has higher volatility (33.75%) compared to TALK (0.90%). In terms of maximum drawdown, LTRN dropped -94.89% vs TALK's -95.17%.

Which has better risk-adjusted returns?

TALK currently has the higher Sharpe Ratio (1.11 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.